Authors
Loading...
Genomic characterization uncovers molecular subtypes in mantle cell lymphoma, suggesting precision therapy using BTK inhibitors for high-risk variants.
Yang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: